Y-mAbs Therapeutics Inc (YMAB)
12.59
+0.19
(+1.53%)
USD |
NASDAQ |
May 24, 11:28
Y-mAbs Therapeutics Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.455M |
| September 30, 2021 | -0.071M |
| June 30, 2021 | -0.041M |
| March 31, 2021 | 61.61M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.044M |
| September 30, 2020 | -2.713M |
| June 30, 2020 | -0.002M |
| March 31, 2020 | -0.026M |
| December 31, 2019 | -1.147M |
| September 30, 2019 | -0.617M |
| June 30, 2019 | -0.075M |
| March 31, 2019 | -0.126M |
| December 31, 2018 | -0.057M |
| September 30, 2018 | -0.053M |
| June 30, 2018 | -0.124M |
| March 31, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.713M
Minimum
Sep 2020
61.61M
Maximum
Mar 2021
3.134M
Average
-0.014M
Median
Cash from Investing (Quarterly) Benchmarks
| The Cooper Companies Inc | -324.10M |
| Puma Biotechnology Inc | -19.08M |
| Humacyte Inc | -0.391M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.477M |
| Cash from Financing (Quarterly) | 0.588M |
| Free Cash Flow | -17.58M |
| Free Cash Flow Per Share (Quarterly) | -0.0794 |
| Free Cash Flow to Equity (Quarterly) | -3.477M |
| Free Cash Flow to Firm (Quarterly) | -3.477M |
| Free Cash Flow Yield | -3.20% |